Inherbin3

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameInherbin3
Drug Alias NameErbB1 antagonist (ENKAM)EGFR antagonist (ENKAM)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnkam Pharmaceuticals A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnkam Pharmaceuticals A/S
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A